129 related articles for article (PubMed ID: 1863827)
21. [Paget, algodystrophy and total hip prosthesis].
May V; Glowinski J
Rev Rhum Mal Osteoartic; 1982 Dec; 49(12):875-7. PubMed ID: 7163754
[No Abstract] [Full Text] [Related]
22. [Predictifs factors of the algodystrophy evolution in a rheumatology department among 60 cases].
Bejia I; Ben Khalifa A; Ben Salah Z; Bejaoui S; Touzi M; Bergaoui N
Tunis Med; 2005 Mar; 83(3):163-7. PubMed ID: 15929446
[TBL] [Abstract][Full Text] [Related]
23. Analgesic effect of nasal salmon calcitonin during the early post-fracture period of the distal radius fracture.
Karponis A; Rizou S; Pallis D; Zafeiris CP; Georgiou DF; Galanos A; Giannoulis F; Lyritis GP
J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):186-9. PubMed ID: 26032211
[TBL] [Abstract][Full Text] [Related]
24. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study.
Hamamci N; Dursun E; Ural C; Cakci A
Br J Clin Pract; 1996; 50(7):373-5. PubMed ID: 9015909
[TBL] [Abstract][Full Text] [Related]
26. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
[TBL] [Abstract][Full Text] [Related]
27. Post-traumatic reflex sympathetic dystrophy syndrome (Sudeck's atrophy): effects of regional guanethidine infusion and salmon calcitonin.
McKay NN; Woodhouse NJ; Clarke AK
Br Med J; 1977 Jun; 1(6076):1575-6. PubMed ID: 68796
[No Abstract] [Full Text] [Related]
28. [Partial algodystrophy].
Doury P; Delahaye RP; Granier R; Pattin S; Metges PJ; Fabresse F
Rev Rhum Mal Osteoartic; 1979 Jan; 46(1):37-44. PubMed ID: 441666
[TBL] [Abstract][Full Text] [Related]
29. [The calcitonin treatment of patients with algodystrophy].
Solarova P; Kŭnev K
Vutr Boles; 1990; 29(5):102-5. PubMed ID: 2080602
[TBL] [Abstract][Full Text] [Related]
30. Nasal calcitonin for treatment of established osteoporosis.
Overgaard K; Riis BJ; Christiansen C; Pødenphant J; Johansen JS
Clin Endocrinol (Oxf); 1989 Apr; 30(4):435-42. PubMed ID: 2688995
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
32. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
[TBL] [Abstract][Full Text] [Related]
33. [Pregnancy-induced algodystrophy].
Perka C; Buttgereit F; Backhaus M
Z Rheumatol; 1998 Dec; 57(6):399-408. PubMed ID: 10025099
[TBL] [Abstract][Full Text] [Related]
34. Reflex sympathetic dystrophy syndrome secondary to organophosphate intoxication induced neuropathy.
Sahin M; Bernay I; Cantürk F; Demirçali AE
Ann Nucl Med; 1994 Nov; 8(4):299-300. PubMed ID: 7535551
[TBL] [Abstract][Full Text] [Related]
35. [Hormonal treatment of fractures with painful post-traumatic healing disorders in stage II and III of Sudeck's disease].
Benz K
Unfallheilkunde; 1983 Oct; 86(10):450-4. PubMed ID: 6196893
[No Abstract] [Full Text] [Related]
36. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of algodystrophies].
Delcambre B; Duquesnoy B; Baudens G; Cocheteux P; Thevenon A; Delfosse JM; Pouyol F
Rev Rhum Mal Osteoartic; 1982 Dec; 49(12):849-56. PubMed ID: 6131528
[TBL] [Abstract][Full Text] [Related]
38. [Use of calcitonin in the treatment of post-traumatic Sudeck syndrome of the lower extremities].
Tantó Z; Molnár L; Keszthelyi B
Magy Traumatol Orthop Helyreallito Seb; 1986; 29(4):284-90. PubMed ID: 2432365
[No Abstract] [Full Text] [Related]
39. [Comparison of the secondary effects produced by synthetic salmon calcitonin administered intramuscularly and in the form of a nasal spray].
Reginster JY; Franchimont P
Rev Med Liege; 1985 Oct; 40(19):667-9. PubMed ID: 4070890
[No Abstract] [Full Text] [Related]
40. [Treatment and evolution of algodystrophy of the foot. Retrospective study of 199 cases].
Eulry F; Aczel F; Vasseur P; Thomas E; Pattin S; Doury P
Ann Med Interne (Paris); 1990; 141(1):20-5. PubMed ID: 2321884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
